Pharmacists in Saint Rose, LA Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Shelley Schmitz Remkes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 Mallard St, Ste C, Saint Rose, LA 70087 Phone: 504-712-7858 Fax: 504-712-4799 |
 William E. Miller Jr., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 Mallard St, Ste. C, Saint Rose, LA 70087 Phone: 800-225-5967 Fax: 909-799-4364 |
Richard Irvin Miller, LA 14443 Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 Riverwood Dr, Saint Rose, LA 70087 Phone: 504-236-3320 Fax: 504-467-2471 |
News Archive
Data shows Take Care Clinics' quality of care exceeds national benchmarks
Take Care Health Systems, a wholly-owned subsidiary of Walgreens and the nation's largest and most comprehensive manager of convenient care clinics and worksite health and wellness centers, today announced that an analysis of de-identified data collected through the company's electronic medical record (EMR) system by the Jefferson School of Population Health showed that the quality of care delivered in Take Care Clinics for treatment of pharyngitis (inflammation of the throat) and upper respiratory infections (URI) meets or exceeds the quality of the care delivered in other settings.
Bariatric surgery can remit or prevent diabetic nephropathy in obese patients
In many obese diabetic patients, one of the most dreaded complications of Type 2 diabetes can be put into remission or prevented entirely with bariatric surgery, according to a new study from the Cleveland Clinic presented here at the 29th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.
Nanotechnology-based vaccine cures mice with type 1 diabetes
Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with type 1 diabetes and slow the onset of the disease in mice at risk for the disease. The study, co-funded by the Juvenile Diabetes Research Foundation, provides new and important insights into understanding how to stop the immune attack that causes type 1 diabetes, and could even have implications for other autoimmune diseases.
Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets
Mundipharma International Limited's network of independent associated companies are launching Remsima® (infliximab) this month in Germany, Italy, UK, Netherlands, Belgium and Luxembourg following expiry of the relevant patents and Supplementary Protection Certificates, having secured distribution rights from Celltrion Healthcare Hungary Kft for Remsima in these markets.
WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19
A large-scale randomized trial has recently been conducted by the World Health Organization (WHO) to evaluate the efficacy of four repurposed antiviral medicines, including Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon, currently used to treat hospitalized coronavirus disease 2019 (COVID-19) patients.
› Verified 9 days ago